FORA Capital’s Amedisys AMED Stock Holding History

FORA Capital’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,734	Closed	-$707K	–	448
2023 Q2	$707K	Buy	7,734 +3,256	+73%	+$267K	0.1%	197
2023 Q1	$329K	Buy	+4,478	New	+$387K	0.03%	421
2022 Q3	–	Sell	-2,619	Closed	-$275K	–	402
2022 Q2	$275K	Buy	+2,619	New	+$335K	0.05%	348
2021 Q4	–	Sell	-6,257	Closed	-$933K	–	302
2021 Q3	$933K	Buy	6,257 +5,080	+432%	+$1.06M	0.24%	130
2021 Q2	$288K	Buy	+1,177	New	+$309K	0.05%	362
2020 Q4	–	Sell	-308	Closed	-$73K	–	904
2020 Q3	$73K	Buy	+308	New	+$70K	0.05%	370
2020 Q2	–	Sell	-1,554	Closed	-$285K	–	869
2020 Q1	$285K	Sell	1,554 -2,212	-59%	-$394K	0.06%	361
2019 Q4	$629K	Buy	+3,766	New	+$560K	0.06%	342

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

FORA Capital's AMED Position: Q3 2023 in Review

FORA Capital sold out of Amedisys (AMED) in Q3 2023, closing a stake of 7,734 shares — an estimated $707K sold.

FORA Capital first reported a position in AMED in Q4 2019 and held it in 8 quarters. The position peaked at $933K in Q3 2021. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

FORA Capital reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
FORA Capital sold 7,734 Amedisys shares in Q3 2023, an estimated $707K.
FORA Capital first reported a position in Amedisys in Q4 2019 and held it in 8 quarters.
FORA Capital's Amedisys position peaked at $933K in Q3 2021.
286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on FORA Capital's 13F filing for Q3 2023, filed 13 Nov 2023.